Type 2 diabetes coronary heart disease unspecified
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) Patients diagnosed and treated by academic successors of the [specific] school of traditional Chinese medicine who meet the above-mentioned diagnostic criteria of both traditional Chinese medicine and Western medicine. (2) No gender restrictions aged between 18 and 80 years old. (3) Patients who have not participated in any other clinical trials within the past 3 months. (4) The participants themselves have been informed and have given their consent and they voluntarily sign the informed consent form.
Exclusion criteria
Exclusion criteria: (1) Patients with diabetes and coronary heart disease complicated by severe complications such as myocardial infarction heart failure atrial fibrillation post-coronary artery bypass grafting diabetic nephropathy diabetic foot diabetic retinopathy etc. are excluded. (2) Pregnant or breastfeeding women as well as women who plan to become pregnant or do not have a contraception plan. (3) Patients with abnormal liver or kidney function. (4) Patients with coagulation disorders or abnormal immune system severe organ dysfunction severe mental illness or cognitive impairment are excluded. (5) Individuals known to be allergic to the drugs used in this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Cardiac function indicators;Glucose metabolism indicators; | — |
Secondary
| Measure | Time frame |
|---|---|
| Blood lipid levels;Safety Indicators;TCM Syndrome Indices; | — |
Countries
China
Contacts
Beijing University of Chinese Medicine Dongzhimen Hospital